Hervolution Therapeutics
Copenhagen
About Hervolution Therapeutics
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: hervolutiontx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/hervolution-therapeutics-11319 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.